6-51753157-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_138694.4(PKHD1):c.8950+44A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00351 in 1,565,510 control chromosomes in the GnomAD database, including 148 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.018 ( 79 hom., cov: 33)
Exomes 𝑓: 0.0020 ( 69 hom. )
Consequence
PKHD1
NM_138694.4 intron
NM_138694.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.201
Publications
0 publications found
Genes affected
PKHD1 (HGNC:9016): (PKHD1 ciliary IPT domain containing fibrocystin/polyductin) The protein encoded by this gene is predicted to have a single transmembrane (TM)-spanning domain and multiple copies of an immunoglobulin-like plexin-transcription-factor domain. Alternative splicing results in two transcript variants encoding different isoforms. Other alternatively spliced transcripts have been described, but the full length sequences have not been determined. Several of these transcripts are predicted to encode truncated products which lack the TM and may be secreted. Mutations in this gene cause autosomal recessive polycystic kidney disease, also known as polycystic kidney and hepatic disease-1. [provided by RefSeq, Jul 2008]
PKHD1 Gene-Disease associations (from GenCC):
- autosomal recessive polycystic kidney diseaseInheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Myriad Women’s Health, Orphanet
- polycystic kidney disease 4Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Laboratory for Molecular Medicine, Genomics England PanelApp
- Caroli diseaseInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 6-51753157-T-C is Benign according to our data. Variant chr6-51753157-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 262424.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-51753157-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 262424.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-51753157-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 262424.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-51753157-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 262424.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.059 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0179 AC: 2720AN: 152212Hom.: 79 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
2720
AN:
152212
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00526 AC: 1308AN: 248872 AF XY: 0.00381 show subpopulations
GnomAD2 exomes
AF:
AC:
1308
AN:
248872
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00197 AC: 2777AN: 1413180Hom.: 69 Cov.: 25 AF XY: 0.00172 AC XY: 1212AN XY: 704632 show subpopulations
GnomAD4 exome
AF:
AC:
2777
AN:
1413180
Hom.:
Cov.:
25
AF XY:
AC XY:
1212
AN XY:
704632
show subpopulations
African (AFR)
AF:
AC:
1989
AN:
32458
American (AMR)
AF:
AC:
255
AN:
44354
Ashkenazi Jewish (ASJ)
AF:
AC:
2
AN:
25698
East Asian (EAS)
AF:
AC:
0
AN:
39334
South Asian (SAS)
AF:
AC:
17
AN:
85030
European-Finnish (FIN)
AF:
AC:
0
AN:
53262
Middle Eastern (MID)
AF:
AC:
26
AN:
5652
European-Non Finnish (NFE)
AF:
AC:
237
AN:
1068618
Other (OTH)
AF:
AC:
251
AN:
58774
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
136
272
408
544
680
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
66
132
198
264
330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0179 AC: 2720AN: 152330Hom.: 79 Cov.: 33 AF XY: 0.0176 AC XY: 1312AN XY: 74500 show subpopulations
GnomAD4 genome
AF:
AC:
2720
AN:
152330
Hom.:
Cov.:
33
AF XY:
AC XY:
1312
AN XY:
74500
show subpopulations
African (AFR)
AF:
AC:
2534
AN:
41558
American (AMR)
AF:
AC:
132
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3472
East Asian (EAS)
AF:
AC:
0
AN:
5192
South Asian (SAS)
AF:
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
AC:
0
AN:
10632
Middle Eastern (MID)
AF:
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
AC:
27
AN:
68032
Other (OTH)
AF:
AC:
25
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
126
252
377
503
629
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
17
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Mar 09, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Autosomal recessive polycystic kidney disease Benign:1
Apr 13, 2018
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.